{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:13:58Z","timestamp":1761178438420,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.canrad.2013.06.032","type":"journal-article","created":{"date-parts":[[2013,8,28]],"date-time":"2013-08-28T00:17:19Z","timestamp":1377649039000},"page":"566-570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Recommandations pour la d\u00e9lin\u00e9ation des aires ganglionnaires pelviennes dans le cancer du canal anal"],"prefix":"10.1016","volume":"17","author":[{"given":"V.","family":"Vendrely","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Galland-Girodet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Orr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-P.","family":"Maire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2013.06.032_bib0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/cncr.20364","article-title":"Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973\u20132000","volume":"101","author":"Johnson","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2013.06.032_bib0010","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/BF02238600","article-title":"Combined therapy for cancer of the anal canal: a preliminary report, 1974","volume":"36","author":"Nigro","year":"1993","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.canrad.2013.06.032_bib0015","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canala randomized controlled trial","volume":"299","author":"Ajani","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.canrad.2013.06.032_bib0020","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","article-title":"Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)","volume":"102","author":"Northover","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.canrad.2013.06.032_bib0025","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"Bartelink","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2013.06.032_bib0030","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0021-7697(08)74312-6","article-title":"R\u00e9section R0, seul facteur pronostique dans les amputations abdominop\u00e9rin\u00e9ales de rattrapage des cancers du canal anal (s\u00e9rie cons\u00e9cutive de 95\u00a0patients)","volume":"145","author":"Rouquie","year":"2008","journal-title":"J Chir (Paris)"},{"key":"10.1016\/j.canrad.2013.06.032_bib0035","first-page":"1","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2\u00d72\u00a0factorial trial","author":"Ajani","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2013.06.032_bib0040","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijrobp.2010.09.030","article-title":"Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy","volume":"82","author":"Kachnic","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.06.032_bib0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1748-717X-7-45","article-title":"IMRT for locally advanced anal cancer: clinical experience of the Montpellier Cancer Center","volume":"7","author":"Vieillot","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2013.06.032_bib0050","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2011.35.4837","article-title":"Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03\u00a0Trial","volume":"30","author":"Peiffert","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2013.06.032_bib0055","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ijrobp.2011.07.007","article-title":"Twenty-five-year experience with radical chemoradiation for anal cancer","volume":"83","author":"Tomaszewski","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.06.032_bib0060","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0360-3016(96)00493-2","article-title":"Conservative treatment by irradiation of epidermoid cancers of the anal canal: prognostic factors of tumoral control and complications","volume":"37","author":"Peiffert","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.06.032_bib0065","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ijrobp.2009.09.029","article-title":"Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning","volume":"78","author":"Wright","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.06.032_bib0070","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ijrobp.2008.08.070","article-title":"Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas","volume":"74","author":"Myerson","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.06.032_bib0075","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ijrobp.2011.12.058","article-title":"Australasian gastrointestinal trials group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer","volume":"83","author":"Ng","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.06.032_bib0080","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1016\/S1278-3218(10)70015-9","article-title":"Cancer du canal anal","volume":"14","author":"Fesneau","year":"2011","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2013.06.032_bib0085","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.radonc.2012.03.007","article-title":"Clinical target volumes in anal cancer: calculating what dose was likely to have been delivered in the UK ACT II trial protocol","volume":"103","author":"Aggarwal","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2013.06.032_bib0090","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ijrobp.2004.09.060","article-title":"Anal canal carcinoma: Early-stage tumors \u226410mm (T1\u00a0or Tis): therapeutic options and original pattern of local failure after radiotherapy","volume":"62","author":"Ortholan","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.06.032_bib0095","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ijrobp.2010.05.050","article-title":"Contrast-Enhanced [18F]fluorodeoxyglucose-positron emission tomography\/computed tomography for staging and radiotherapy planning in patients with anal cancer","volume":"81","author":"Bannas","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.06.032_bib0100","article-title":"Anal carcinoma: FDG PET\/CT in staging, response evaluation, and follow-up","author":"Saboo","year":"2012","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.canrad.2013.06.032_bib0105","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ijrobp.2006.01.009","article-title":"FDG-PET\/CT in the evaluation of anal carcinoma","volume":"65","author":"Cotter","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.06.032_bib0110","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00384-010-1080-9","article-title":"Impact of FDG PET\/CT in the staging and the follow-up of anal carcinoma","volume":"26","author":"Vercellino","year":"2010","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.canrad.2013.06.032_bib0115","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/sj.bjc.6604897","article-title":"The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer","volume":"100","author":"Winton","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.canrad.2013.06.032_bib0120","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijrobp.2009.04.020","article-title":"Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of inguinal node metastases in patients with anal cancer","volume":"77","author":"Mistrangelo","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.06.032_bib0125","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1748-717X-5-10","article-title":"FDG-PET\/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma","volume":"5","author":"Krengli","year":"2010","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2013.06.032_bib0130","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s00066-009-1944-5","article-title":"Can the radiation dose to CT-Enlarged but FDG-PET-negative inguinal lymph nodes in anal cancer be reduced?","volume":"185","author":"Mai","year":"2009","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2013.06.032_bib0135","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.ijrobp.2005.05.062","article-title":"Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy","volume":"63","author":"Taylor","year":"2005","journal-title":"I Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.06.032_bib0140","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.canrad.2011.07.240","article-title":"Radioth\u00e9rapie conformationnelle avec modulation d\u2019intensit\u00e9 des cancers de l\u2019anus","volume":"15","author":"Peiffert","year":"2011","journal-title":"Cancer Radiother"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321813002941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321813002941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:23:45Z","timestamp":1761135825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321813002941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":28,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1278321813002941"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2013.06.032","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommandations pour la d\u00e9lin\u00e9ation des aires ganglionnaires pelviennes dans le cancer du canal anal","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2013.06.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}